Literature DB >> 17272813

Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility.

Natalie Burkard1, Adam G Rokita, Susann G Kaufmann, Matthias Hallhuber, Rongxue Wu, Kai Hu, Ulrich Hofmann, Andreas Bonz, Stefan Frantz, Elizabeth J Cartwright, Ludwig Neyses, Lars S Maier, Sebastian K G Maier, Thomas Renné, Kai Schuh, Oliver Ritter.   

Abstract

The role of the neuronal NO synthase (nNOS or NOS1) enzyme in the control of cardiac function still remains unclear. Results from nNOS(-/-) mice or from pharmacological inhibition of nNOS are contradictory and do not pay tribute to the fact that probably spatial confinement of the nNOS enzyme is of major importance. We hypothesize that the close proximity of nNOS and certain effector molecules like L-type Ca(2+)-channels has an impact on myocardial contractility. To test this, we generated a new transgenic mouse model allowing conditional, myocardial specific nNOS overexpression. Western blot analysis of transgenic nNOS overexpression showed a 6-fold increase in nNOS protein expression compared with noninduced littermates (n=12; P<0.01). Measuring of total NOS activity by conversion of [(3)H]-l-arginine to [(3)H]-l-citrulline showed a 30% increase in nNOS overexpressing mice (n=18; P<0.05). After a 2 week induction, nNOS overexpression mice showed reduced myocardial contractility. In vivo examinations of the nNOS overexpressing mice revealed a 17+/-3% decrease of +dp/dt(max) compared with noninduced mice (P<0.05). Likewise, ejection fraction was reduced significantly (42% versus 65%; n=15; P<0.05). Interestingly, coimmunoprecipitation experiments indicated interaction of nNOS with SR Ca(2+)ATPase and additionally with L-type Ca(2+)- channels in nNOS overexpressing animals. Accordingly, in adult isolated cardiac myocytes, I(Ca,L) density was significantly decreased in the nNOS overexpressing cells. Intracellular Ca(2+)-transients and fractional shortening in cardiomyocytes were also clearly impaired in nNOS overexpressing mice versus noninduced littermates. In conclusion, conditional myocardial specific overexpression of nNOS in a transgenic animal model reduced myocardial contractility. We suggest that nNOS might suppress the function of L-type Ca(2+)-channels and in turn reduces Ca(2+)-transients which accounts for the negative inotropic effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272813     DOI: 10.1161/01.RES.0000259042.04576.6a

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

Review 1.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

2.  CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart.

Authors:  Kuan-Cheng Chang; Andreas S Barth; Tetsuo Sasano; Eddy Kizana; Yuji Kashiwakura; Yiqiang Zhang; D Brian Foster; Eduardo Marbán
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

Review 3.  Physiological implications of the interaction between the plasma membrane calcium pump and nNOS.

Authors:  Elizabeth J Cartwright; Delvac Oceandy; Ludwig Neyses
Journal:  Pflugers Arch       Date:  2008-01-29       Impact factor: 3.657

4.  Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study.

Authors:  Mark Eijgelsheim; Christopher Newton-Cheh; Adrianus L H J Aarnoudse; Charlotte van Noord; Jacqueline C M Witteman; Albert Hofman; André G Uitterlinden; Bruno H C Stricker
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

5.  [Heart failure. Excitation-contraction coupling and novel therapeutic options].

Authors:  A G Rokita; C-M Sag; L S Maier
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

Review 6.  Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology.

Authors:  Yin Hua Zhang; Chun Zi Jin; Ji Hyun Jang; Yue Wang
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

7.  A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Authors:  Matthijs L Becker; Loes E Visser; Christopher Newton-Cheh; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

Review 8.  Redox regulation of sodium and calcium handling.

Authors:  Stefan Wagner; Adam G Rokita; Mark E Anderson; Lars S Maier
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

9.  Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium.

Authors:  Tamer M A Mohamed; Delvac Oceandy; Sukhpal Prehar; Nasser Alatwi; Zeinab Hegab; Florence M Baudoin; Adam Pickard; Aly O Zaki; Raja Nadif; Elizabeth J Cartwright; Ludwig Neyses
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

Review 10.  Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart.

Authors:  Soban Umar; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.